Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stromal Vascular Therapy
- Development stage
- Unknown
- Lead developer
- Cell Surgical Network
- Modality
- Hematopoietic Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Patient-derived iPSCs → iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies, Autologous CAR-T → CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Mesenchymal Stem Cells → Adult Stem Cells → Stem Cell Therapies → Cell Therapies, Tumor-Infiltrating Lymphocytes (TILs) → Native Immune Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Topical, Intradermal
01
Overview
Stromal Vascular Therapy (SVT) is an autologous cell therapy developed by Paracrine for the treatment of chronic wounds. The therapy involves extracting regenerative cells from a patient's own adipose (fat) tissue and applying them directly to the wound site via topical or intradermal administration. The active component is the stromal vascular fraction (SVF), which consists of a heterogeneous population of cells including adipose-derived stem cells, endothelial cells, pericytes, and immune cells. These cells promote healing through paracrine mechanisms, secreting a variety of growth factors and cytokines that stimulate angiogenesis, modulate the inflammatory environment, and facilitate tissue repair and regeneration. Paracrine integrates this regenerative therapy with its AiPara Suite™, an AI-powered platform designed to predict healing likelihood, identify non-responders, and monitor patient progress.
- Other names
- Autologous stromal vascular fraction therapySVF therapyAdipose-derived stromal vascular fraction
Beyond the preview
Go deeper on Stromal Vascular Therapy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Stromal Vascular Therapy.